» Articles » PMID: 16002807

Long-term Moderate Zinc Supplementation Increases Exchangeable Zinc Pool Masses in Late-middle-aged Men: the Zenith Study

Overview
Journal Am J Clin Nutr
Publisher Elsevier
Date 2005 Jul 9
PMID 16002807
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Zinc supplementation may be beneficial for health. Assessing exchangeable zinc pools may be a useful approach to evaluate zinc status.

Objective: We evaluated the effects of long-term supplementation with 2 moderate doses of zinc on the mass of exchangeable zinc pools.

Design: Three groups of healthy, late-middle-aged men (n = 16 per group) participated in a stable-isotope zinc kinetic study after 6 mo of daily supplementation with 0 (placebo), 15, or 30 mg Zn. At the end of the supplementation period, each subject received an intravenous injection of 0.89 mg (70)Zn, and the plasma zinc disappearance curve was monitored for the next 10 d. Two approaches were used to determine the characteristics of the exchangeable zinc pools: 1) formal 3-compartmental modeling and 2) a simplified determination of the total mass of the rapidly exchangeable zinc pool (EZP).

Results: In the placebo group, the exchangeable zinc pool masses for the 3 considered pools were as follows: 2.15, 12.7, and 100.5 mg Zn. The rapidly exchangeable zinc pool mass in the placebo group was 143 mg Zn. Zinc supplementation significantly increased the exchangeable zinc pool masses regardless of the approach used to determine these pools. In addition, these data confirm that exchangeable zinc pool masses correlate positively with total zinc intake and negatively with subject age and do not correlate with plasma zinc concentrations.

Conclusion: Our data show that long-term supplementation with 2 moderate doses of zinc is an efficient way to increase exchangeable zinc pool masses in late-middle-aged men.

Citing Articles

Effects of zinc and vitamin A supplementation on prognostic markers and treatment outcomes of adults with pulmonary tuberculosis: a systematic review and meta-analysis.

Wagnew F, Alene K, Eshetie S, Wingfield T, Kelly M, Gray D BMJ Glob Health. 2022; 7(9).

PMID: 36130775 PMC: 9490634. DOI: 10.1136/bmjgh-2022-008625.


Zinc supplementation as an adjunct therapy for COVID-19: Challenges and opportunities.

Chinni V, El-Khoury J, Perera M, Bellomo R, Jones D, Bolton D Br J Clin Pharmacol. 2021; 87(10):3737-3746.

PMID: 33742473 PMC: 8250380. DOI: 10.1111/bcp.14826.


Randomised controlled trial for high-dose intravenous zinc as adjunctive therapy in SARS-CoV-2 (COVID-19) positive critically ill patients: trial protocol.

Perera M, El Khoury J, Chinni V, Bolton D, Qu L, Johnson P BMJ Open. 2020; 10(12):e040580.

PMID: 33268419 PMC: 7712927. DOI: 10.1136/bmjopen-2020-040580.


Analysis of Blood Concentrations of Zinc, Germanium, and Lead and Relevant Environmental Factors in a Population Sample from Shandong Province, China.

Li L, Xu G, Shao H, Zhang Z, Pan X, Li J Int J Environ Res Public Health. 2017; 14(3).

PMID: 28245579 PMC: 5369063. DOI: 10.3390/ijerph14030227.


Biophysical Studies of the Induced Dimerization of Human VEGF Receptor 1 Binding Domain by Divalent Metals Competing with VEGF-A.

Gaucher J, Reille-Seroussi M, Gagey-Eilstein N, Broussy S, Coric P, Seijo B PLoS One. 2016; 11(12):e0167755.

PMID: 27942001 PMC: 5152890. DOI: 10.1371/journal.pone.0167755.